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When is a virus 
an exosome?
 
bold new theory suggests that 
retroviruses have hijacked an inter-
cellular communication system for 
both their biogenesis and spread. The 
concept, outlined by Stephen Gould, 
Amy Booth, and James Hildreth (Johns 
Hopkins University, Baltimore, MD) 
has implications for HIV treatment and 
immunization strategies, and may 
explain why tissue rejection occurs 
in humans.
Hildreth was looking at human 
proteins that HIV acquires during its 
biogenesis, and noticed that lysosomal 
proteins were in the mix. This ties in 
with recent findings in this and other 
journals that HIV is packaged in late 
endosomes (for review see Amara and 
Littman, 2003).
In uninfected cells, this endosomal 
compartment invaginates to form small, 
internal vesicles. The bag of vesicles, or 
multivesicular body, can fuse with the 
plasma membrane to disgorge these 
vesicles, named exosomes, which then 
travel to other cells to transmit messages. 
In the immune system, exosomes transfer 
peptide-laden MHC proteins to non-
infected cells, and also act as miniature 
versions of antigen-presenting cells.
Hildreth now proposes that “the virus 
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Centromere errors get chewed out
 
icrotubule (MT) ends that invade into the inner centro-
mere may get chewed up, say Ryoma Ohi, Timothy 
Mitchison (Harvard Medical School, Boston, MA), and 
colleagues. The process should help prevent MTs emanating 
from a single pole from attaching to both sister kinetochores.
Ohi proposes that the chewing is performed by the KinI 
kinesin MCAK. He found a new MT-binding protein, ICIS, 
that binds to MCAK, relies on it for localization at the inner 
centromere, and further activates MCAK’s MT-depolymerizing 
activity in vitro.
Although ICIS depletion causes widespread MT poly-
merization, probably because of co-depletion of MCAK, it 
almost certainly has a more specific function at the inner 
centromere. Just away from the inner centromere—specifically 
near the kinetochore—a high density of MTs is desirable if 
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is fully an exosome in every sense of 
the word.” Others have found that HIV 
particles contain MHC, but by the 
exosome hypothesis they may also 
contain proteins that exosomes use 
to fuse with target cells and to avoid 
attack by complement. As Gould points 
out, an exosome makes a perfect vector 
for HIV, because an exosome “is not 
just proteins in a vesicle, it’s something 
that is meant to traffic.”
The idea may explain how HIV both 
infects cells that lack receptors for its 
surface gp120 protein, and avoids 
robust, virus-directed immune 
responses. “Even if one completely 
blocks the gp120-related pathway 
of entry, HIV will have this second, 
albeit less efficient, means of getting 
into cells,” says Hildreth.
To block all entry, suggests Hildreth, 
perhaps the MHC should be the target. 
Alloimmunization—immunization 
with a wide range of MHC and other 
protein variants (e.g., by injecting 
killed leukocytes)—might allow a 
newly infected individual to mount a 
quick attack on the incoming HIV, 
which is packed with foreign MHC. 
Gould even suggests, “this is why we 
have tissue rejection responses—
[they evolved] to protect us from retro-
viruses.” He points out that alloimmunity 
predates and thus could not have 
arisen from adaptive immunity.
The more extreme idea of xeno-
immunization does work in monkeys, 
which can reject SIV grown in human 
cells. And for Thomas Lehner (Guy’s 
Hospital, London, UK), who has been 
pushing the idea for several years, 
alloimmunization “is far better than 
anything we have at the moment.” 
But it has languished since the monkey 
experiment, perhaps based on fears 
that it would prevent later transplants, 
cause rejection during pregnancies, 
and fail to catch a handful of HIV 
particles before they replicate and thus 
incorporate self-MHC.
Mark Feinberg (Emory University, 
Atlanta, GA) warns, “for a protective 
vaccine, the regulatory environment 
is exceedingly conservative, because 
you are dealing with healthy people.” 
Even if concerns such as transplantation 
are of little importance in the develop-
ing world, a vaccine developed in 
the industrialized world will have to 
follow the exacting standards of bodies 
such as the US Food and Drug Admin-
istration (FDA). Unfortunately, says 
Feinberg, “the FDA goes off in one 
direction, and the epidemic goes off 
in another.” 
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the cell is to ensure 
kinetochore 
capture. “But it’s 
also dangerous,” 
says Ohi. Slightly 
errant MTs can 
skirt around the 
closest kineto-
ICIS (red, left) helps destroy invading 
microtubules (red, right).
Ohi/Elsevier
 
chore, cross the inner centromere, and attach to the more 
distant kinetochore. Ohi predicts that ICIS-stimulated 
MCAK intercepts these MTs before they can reach their 
incorrect target. He now proposes to test whether interference 
with the MCAK/ICIS system causes attachment errors, as 
his model predicts.
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